As shown in Fig 4A treatment with the PLK1 inhibitor rigosertib resulted in a drop of the SAD value (5.415 ± 0.2484, p = 0.0067) when compared to untreated MDS-L cells (7.265 ± 0.5991). The gene discussed is PLK1; the disease is myelodysplastic syndrome.